COLLEGIUM PHARMACEUTICAL, INC
COLL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267565
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
287
- +12 vs. Q1 2026
- Total value $2.07B
Superinvestors holding COLL
0
- None of the superinvestors held COLL at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by COLL insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | May 18, 2026 | Freund John GordonDirector | SSaleCommon Stock | −20 | $34.05 | −$681 | 83.95K | 0.0% | SEC |
| May 18, 2026 | May 15, 2026 | Freund John GordonDirector | SSaleCommon Stock | −4.13K | $34.54 | −$142.55K | 83.97K | −4.7% | SEC |
| May 15, 2026 | May 13, 2026 | Lurker NancyDirector | SSaleCommon Stock | −4.5K | $35.97 | −$161.87K | 18.02K | −20.0% | SEC |
| May 13, 2026 | May 11, 2026 | BOHLIN GAREN GDirector | SSaleCommon Stock | −8.7K | $37.18 | −$323.47K | 62.26K | −12.3% | SEC |
| Mar 20, 2026 | Mar 18, 2026 | Dieter DavidEVP & General Counsel | SSaleCommon Stock | −13.98K | $34.92 | −$488.04K | 77.07K | −15.4% | SEC10b5-1 |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in COLL at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Banque Cantonale Vaudoise | 9,457 | $342M | 0.05% | +9,457 | New |
| BlackRock, Inc. | 5,441,202 | $196.97M | 0.00% | +307,175+6.0% | Added |
| Linden Advisors LP | – | $171.68M | 0.89% | – | – |
| TENOR CAPITAL MANAGEMENT Co., L.P. | – | $85.79M | 1.21% | – | – |
| Jupiter Topco LLC | 2,147,072 | $77.74M | 0.03% | +2,147,072 | New |